Nicolaou; Michalis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nicolaou; Michalis.The latest application filed is for "target-enriched multiplexed parallel analysis for assessment of risk for genetic conditions".

Company Profile

1.4.10

Nicolaou; Michalis - Nicosia CY
Nicolaou; Michalis - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Target-enriched Multiplexed Parallel Analysis For Assessment Of Risk For Genetic Conditions App 20210147937 - Koumbaris; George ; et al.	2021-05-20
GLP-1 receptor agonist bioassay Grant 8,603,761 - Nicolaou , et al. December 10, 2	2013-12-10
Glp-1 Receptor Agonist Bioassay App 20130089878 - Nicolaou; Michalis ; et al.	2013-04-11
Treatment Of Diseases Modulated By A H4 Receptor Agonist App 20130059878 - Loria; Emile ; et al.	2013-03-07
GLP-1 receptor agonist bioassays Grant 8,329,419 - Nicolaou , et al. December 11, 2	2012-12-11
Treatment Of Copd, Gastro-esophageal Reflux Disease (gerd), Food Allergies And Other Gastrointestinal Conditions And Disorders Ameliorated By Proper Histamine Management Using A Combination Of Histidine Decarboxylase Inhibators, Lra Drugs, Anti-h1 And/or Anti-h2 Drugs App 20120295933 - Loria; Emile ; et al.	2012-11-22
Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs Grant 8,207,292 - Nicolaou , et al. June 26, 2	2012-06-26
Treatment of diseases modulated by a H4 receptor agonist Grant 8,207,188 - Nicolaou , et al. June 26, 2	2012-06-26
Pure Isomers Of Tritoqualine App 20120101120 - Nicolaou; Michalis ; et al.	2012-04-26
Glp-1 Receptor Agonist Bioassays App 20110097751 - Nicolaou; Michalis ; et al.	2011-04-28
Treatment Of Diseases Modulated By A H4 Receptor Agonist App 20100144718 - Nicolaou; Michalis ; et al.	2010-06-10
Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs App 20080207530 - Nicolaou; Michalis ; et al.	2008-08-28
Pure isomers of tritoqualine App 20070238750 - Nicolaou; Michalis ; et al.	2007-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.